ArTS Archivio della ricerca di Trieste

SBLATTERO, DANIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 31.818
EU - Europa 19.740
AS - Asia 18.189
SA - Sud America 5.528
AF - Africa 657
Continente sconosciuto - Info sul continente non disponibili 551
OC - Oceania 403
Totale 76.886
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 29.685
CN - Cina 6.085
IT - Italia 5.367
BR - Brasile 3.342
SG - Singapore 2.630
DE - Germania 1.724
PL - Polonia 1.688
ES - Italia 1.609
MX - Messico 1.304
GB - Regno Unito 1.271
FR - Francia 1.221
JP - Giappone 1.187
TR - Turchia 1.185
SE - Svezia 1.153
IN - India 1.145
VN - Vietnam 1.083
HK - Hong Kong 977
UA - Ucraina 859
ID - Indonesia 781
KR - Corea 694
FI - Finlandia 592
NL - Olanda 589
CA - Canada 551
CO - Colombia 503
AR - Argentina 490
PT - Portogallo 479
RU - Federazione Russa 479
TW - Taiwan 450
PE - Perù 391
CL - Cile 353
GR - Grecia 353
AU - Australia 337
BD - Bangladesh 296
AT - Austria 285
CH - Svizzera 266
TH - Thailandia 260
IE - Irlanda 257
EC - Ecuador 236
BE - Belgio 235
RO - Romania 206
BG - Bulgaria 196
SA - Arabia Saudita 191
PK - Pakistan 175
DK - Danimarca 166
EG - Egitto 152
IR - Iran 142
IL - Israele 119
CZ - Repubblica Ceca 111
MA - Marocco 111
HU - Ungheria 106
MY - Malesia 101
PH - Filippine 94
IQ - Iraq 91
ZA - Sudafrica 87
HR - Croazia 84
VE - Venezuela 81
SI - Slovenia 74
RS - Serbia 71
NZ - Nuova Zelanda 63
TN - Tunisia 63
LB - Libano 54
LT - Lituania 54
NO - Norvegia 54
LV - Lettonia 51
JO - Giordania 47
PA - Panama 47
AE - Emirati Arabi Uniti 46
CR - Costa Rica 43
KZ - Kazakistan 43
UY - Uruguay 43
GT - Guatemala 41
PY - Paraguay 41
BO - Bolivia 40
UZ - Uzbekistan 37
SK - Slovacchia (Repubblica Slovacca) 36
DZ - Algeria 35
NG - Nigeria 32
HN - Honduras 27
QA - Qatar 27
NP - Nepal 26
PS - Palestinian Territory 26
LK - Sri Lanka 25
KE - Kenya 24
DO - Repubblica Dominicana 22
SY - Repubblica araba siriana 22
BY - Bielorussia 20
EU - Europa 20
OM - Oman 20
CY - Cipro 19
EE - Estonia 19
ET - Etiopia 18
AZ - Azerbaigian 17
SN - Senegal 17
NI - Nicaragua 16
PR - Porto Rico 16
GE - Georgia 15
KW - Kuwait 13
MD - Moldavia 13
SV - El Salvador 13
BA - Bosnia-Erzegovina 12
Totale 76.067
Salva come PNG Salva come JPEG
Città #
Ashburn 9.855
Singapore 1.615
Woodbridge 1.545
Fairfield 1.443
Houston 1.436
Ann Arbor 1.386
Warsaw 1.153
Germantown 1.013
Chandler 935
San Jose 844
Beijing 763
Jacksonville 745
Milan 692
Wilmington 692
Seattle 684
Hong Kong 682
Trieste 585
Rome 547
São Paulo 547
Cambridge 517
Seoul 442
Dallas 414
Madrid 413
Shanghai 378
Hefei 377
Council Bluffs 370
Ho Chi Minh City 364
Los Angeles 363
Guangzhou 353
Munich 351
Chicago 345
Tokyo 329
Princeton 316
Istanbul 306
Izmir 306
Boardman 284
Hanoi 277
Columbus 276
Frankfurt am Main 257
New York 253
Lima 252
Rio de Janeiro 252
Barcelona 250
Paris 247
Dublin 237
Helsinki 225
Bogotá 215
Hangzhou 214
Moscow 194
The Dalles 191
Athens 185
Santiago 183
Buenos Aires 182
Taipei 179
Sofia 176
Jakarta 174
Lisbon 171
Ankara 168
Vienna 166
Naples 158
Santa Clara 154
Lauterbourg 153
Zgierz 152
Chengdu 149
Amsterdam 148
Turin 147
Bengaluru 139
Bologna 139
Bangkok 138
London 138
Buffalo 137
Florence 136
Nanjing 129
Curitiba 121
Chennai 119
Brasília 116
Mumbai 109
Medellín 107
Hyderabad 105
Berlin 104
Washington 104
Zurich 104
Las Vegas 102
Melbourne 101
Brussels 99
Toronto 99
Jinan 98
Valencia 98
Quito 95
San Diego 95
Wuhan 95
Montreal 93
Porto Alegre 93
Sydney 93
Boston 92
Belo Horizonte 91
Guadalajara 90
Porto 90
Copenhagen 89
Goiânia 88
Totale 43.021
Salva come PNG Salva come JPEG
Nome #
Bispecific antibodies targeting tumor-associated antigens and neutralizing complement regulators increase the efficacy of antibody-based immunotherapy in mice. 44.816
SINEUPs are modular antisense long non-coding RNAs that increase synthesis of target proteins in cells 446
Targeted delivery of neutralizing anti-C5 antibody to renal endothelium prevents complement- dependent tissue damage 419
Tissue transglutaminase (TG2) enables survival of human malignant pleural mesothelioma cells in hypoxia 359
Targeting CD34+ cells of the inflamed synovial endothelium by guided nanoparticles for the treatment of rheumatoid arthritis 348
A non-complement-fixing antibody to  2 glycoprotein I as a novel therapy for antiphospholipid syndrome 343
Rational design of antirheumatic prodrugs specific for sites of inflammation 341
A reliable screening procedure for coeliac disease in clinical practice. 312
Anti transglutaminase antibodies cause ataxia in mice. 312
Anti-transglutaminase antibodies and age. 308
An Albumin-Derived Peptide Scaffold Capable of Binding and Catalysis 307
A novel quantitative ELISA as accurate and reproducible tool to detect epidermal transglutaminase antibodies in patients with Dermatitis Herpetiformis 307
One-step cloning of anti tissue transglutaminase scFv from subjects with celiac disease. 303
Selecting soluble/foldable protein domains through single-gene or genomic ORF filtering: structure of the head domain of Burkholderia pseudomallei antigen BPSL2063 297
Testing for Anti-Human Transglutaminase Antibodies in Saliva Is Not Useful for Diagnosis of Celiac Disease 296
Analyzing the peripheral blood antibody repertoire of a celiac disease patient using phage antibody libraries 296
Diagnostic Delays in Children with Coeliac Disease in the Central European Region 279
SINEUPs: A new class of natural and synthetic antisense long non-coding RNAs that activate translation 278
Phage display technology for human monoclonal antibodies 263
Clinical Presentation in Children With Coeliac Disease in Central Europe 261
Looking for celiac disease: diagnostic accuracy of two rapid commercial assays 257
A method for rapid and high-yield production of the tick-borne encephalitis virus E and DIII recombinant proteins in E. coli with preservation of the antigenic properties 257
The analysis of the fine specificity of celiac disease antibodies using tissue transglutaminase fragments 256
An Air-well sparging minifermenter system for high-throughput protein production 256
Construction of miniantibodies for the in vivo study of human autoimmune diseases in animal models 253
Role of anti-osteopontin antibodies in multiple sclerosis and experimental autoimmune encephalomyelitis 253
Using archaeal histones for precise DNA fragmentation , 20: 267-271 (2007) 252
A Human Monoclonal Antibody Against Domain I Of beta 2-Glycoprotein I prevents Clotting and Fetal Loss Induced By Polyclonal Anti-Phospholipid Antibodies In Animal Models. 248
Recombinant antibody selections by combining phage and yeast display 248
Dual sugar gut-permeability testing on blood drop in animal models. 244
Autoantibodies as predictors of disease. 242
The Use of Biopsy and "no-Biopsy" Approach for Diagnosing Paediatric Coeliac Disease in the Central European Region 241
Controlling complement resistance in cancer by using human monoclonal antibodies that neutralize complement-regulatory proteins CD55 and CD59 240
Antibodies in haystacks: how selection strategy influences the outcome of selection from molecular diversity libraries 239
A definitive set of oligonucleotide primers for amplifying human V regions 239
A Functional Idiotype/Anti-Idiotype Network Is Active in Genetically Gluten-Intolerant Individuals Negative for Both Celiac Disease-Related Intestinal Damage and Serum Autoantibodies 237
The gut as site of production of autoimmune antibodies. 236
Characterization of the anti-tissue transglutaminase antibody response in nonobese diabetic mice. 234
Prevention of arthritis by locally synthesized recombinant antibody neutralizing complement component C5 231
A deep-blue OLED-based biochip for protein microarray fluorescence detection 231
Molecular dissection of the tissue transglutaminase auto-antibody response in celiac disease 226
Anti-alpha enolase autoantibodies in coeliac disease 226
Impaired glycosylation blocks DPP10 cell surface expression and alters the electrophysiology of i to channel complex 226
Anti tTG autoantibodies crossreacting with brain structures are produced in the intestine in celiac patient with equilibrium disorder 225
A label-free immunoassay for Flavivirus detection by the Reflective Phantom Interface technology 224
Anti-idiotypic response in mice expressing human autoantibodies. 223
Primer sets for cloning the human repertoire of T cell Receptor variable regions 223
Antibodies to transglutaminasefrom phage display libraries 219
N-glycosylation of the mammalian dipeptidyl aminopeptidase-like protein 10 (DPP10) regulates trafficking and interaction with Kv4 channels 216
Antibodies in proteomics II: screening, high-throughput characterization and downstream applications 215
Antibodies against breain structures in a celiac patient with ataxic syndrome are produced in the intestine 215
Interactome-Seq: A Protocol for Domainome Library Construction, Validation and Selection by Phage Display and Next Generation Sequencing 215
Antibodies in proteomics I: generating antibodies 213
Development of a novel rapid non-invasive screening test for coeliac disease. 213
Recombinant renewable polyclonal antibodies 210
Gluten ataxia: passive transfer in a mouse model. 205
A zonulin-occludens toxin synthetic esapeptide modifies the intestinal permeabilità in in-vivo animal model 205
Mapping the minimum domain of the fibronectin binding site on transglutaminase 2 (TG2) and its importance in mediating signaling, adhesion, and migration in TG2-expressing cells 204
Management of coeliac disease patients after the confirmation of diagnosis in Central Europe 204
Molecular dissection of the tissue transglutaminase autoantibody response in celiac disease 203
OP0023 Targeted Polymeric Nanoparticles as Diagnostic and Therapeutic Tool for Rheumatoid Arthritis 201
"Recombinant antibodies against human type ii transglutaminase and uses thereof" 199
Differential induction of IL-17, IL-10, and IL-9 in human T helper cells by B7h and B7.1 199
A single conformational transglutaminase 2 epitope contributed by three domains is critical for celiac antibody binding and effects 199
Humoral immune response to tissue transglutaminase is related to epithelial cell proliferation in celiac disease 198
The transmembrane β-subunits KCNE1, KCNE2, and DPP6 modify pharmacological effects of the antiarrhythmic agent tedisamil on the transient outward current i to 196
Human recombinant tissue transglutaminase ELISA: an innovative diagnostic assay for celiac disease. 196
Thrombus formation induced by antibodies to beta2-glycoprotein I is complement dependent and requires a priming factor. 195
Treatment of experimental arthritis by targeting synovial endothelium with a neutralizing recombinant antibody to C5. 194
Triggering of B7h by the ICOS modulates maturation and migration of monocyte-derived dendritic cells 193
Celiac disease in patients with sporadic and inherited cardiomyopathies and in their relatives. 191
Protective role of anti-idiotypic network in celiac disease prone subjects 190
Extending filamentous phage host range by the grafting of a heterologous receptor binding domain 189
Charecterization of tissue transglutaminase auto-antigenic response using cloned structural domains 185
Mass screening for coeliac disease using antihuman transglutaminase antibody assay. 183
Cloning and characyerization of intestinal antibodies to tissue transglutaminase in celiac disease patients 183
Mucosal tissue transglutaminase expression in celiac disease 183
DEVELOPMENT OF CHLORAMBUCIL/HYDROXYCHLOROQUINE-LOADED ANTI-CD20 NANOPARTICLES FOR THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA : IN VITRO MODEL 182
Profiling the Autoantibody Repertoire by Screening Phage-Displayed Human cDNA Libraries 182
Anti-tissue transglutaminase antibodies activate intracellular tissue transglutaminase by modulating cytosolic Ca2+ homeostasis 181
Prevalence of celiac disease among risk groups and the general population in USA 180
Usefulness of gluten-free diet in gluten-genetically predisposed subjects positive to intestinal mucosa anti-transglutaminase antibodies 180
Site of syntesis of antibodies to A-gliadin and tissue-transglutaminase in celiac disease patients 180
A novel complement-fixing IgM antibody targeting GPC1 as a useful immunotherapeutic strategy for the treatment of pancreatic ductal adenocarcinoma 179
Profiling celiac disease antibody repertoire 179
Protective role of anti-idiotypic network in celiac disease prone subjects 178
Cryptic gluten intolerance in type 1 diabetes: identifying suitable candidates for a gluten free diet. 176
In vivo recombination as a tool to generate molecular diversity in phage antibody libraries 175
Usefulness of gluten-free diet in gluten-genetically predisposed subjects positive to intestinal-mucosa anti-transglutaminase antibodies 175
Celiac anti-type 2 transglutaminase antibodies induce phosphoproteome modification in intestinal epithelial caco-2 cells 175
Filtering "genic" open reading frames from genomic DNA samples for advanced annotation 175
Rapid characterization of VH-5 family specific anti-tTG intestinal antibodies in celiac and autoimmune patients 174
Plasmid incompatibility: More compatible than previously thought? 174
Antibody library selection by the {beta}-lactamase protein fragment complementation assay 174
Defining the Helicobacter pylori Disease-Specific Antigenic Repertoire 173
Proteomic studies of the biofilm matrix including outer membrane vesicles of burkholderia multivorans c1576, a strain of clinical importance for cystic fibrosis 172
FRI0030 Anti-TNF-α Antibody Targeted To Inflamed Synovial Tissue for The Treatment of Rheumatoid Arthritis 171
Majority of children with type 1 diabetes produce and deposit anti-tissue transglutaminase antibodies in the small intestine. 169
Selection and characterization of highly specific recombinant antibodies against West Nile Virus E protein 169
Selection and characterization of a novel agonistic human recombinant anti-TRAIL-R2 minibody with anti-leukemic activity. 166
Totale 67.408
Salva come PNG Salva come JPEG
Categoria #
all - tutte 138.421
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 138.421
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.499 0 0 68 138 65 155 74 55 206 177 139 422
2022/20232.648 253 328 213 379 265 483 26 238 285 25 115 38
2023/20241.458 80 78 72 93 154 192 222 271 22 36 132 106
2024/202522.129 40 159 256 319 376 440 241 242 523 417 6.047 13.069
2025/202635.126 5.986 5.063 5.919 5.547 5.332 2.576 1.225 342 1.027 1.238 480 391
2026/20271.197 352 472 373 0 0 0 0 0 0 0 0 0
Totale 76.886